Table 3.
Associations with outcomes: adequate reperfusion (Thrombolysis in Cerebral Infarction, TICI 2b-3), intracerebral hemorrhage (ICH), and 90-day functional independence (modified Rankin scale, mRS 0–2). #All patients with occluded stents received at least one antiplatelet agent. Abbreviations: ICA internal carotid artery, DAPT dual antiplatelet therapy, OR odds ratio, CI confidence interval.
| TICI 2b-3 | ICH | 90-Day mRS 0–2 | Stent Patency | |||||
|---|---|---|---|---|---|---|---|---|
| P | OR (95%CI) | P | OR (95%CI) | P | OR (95%CI) | P | OR (95%CI) | |
| Among Accessible ICAs (N=55) | ||||||||
| Dissection (15) vs Atherosclerosis | 0.334 | 0.55 (0.16–1.85) | 0.876 | 0.87 (0.16–4.88) | 0.880 | 1.11 (0.30–4.10) | - | - |
| Stenting (34) vs Not | 0.874 | 0.91 (0.29–2.87) | 0.475 | 1.86 (0.34–10.24) | 0.479 | 0.64 (0.19–2.19) | - | - |
| Cervical ICA First (34) vs Last/Deferring | 0.347 | 0.57 (0.18–1.84) | 0.138 | 5.19 (0.59–45.58) | 0.879 | 1.10 (0.32–3.75) | - | - |
| Number EVT Passes | 0.163 | 0.65 (0.36–1.19) | 0.167 | 0.44 (0.14–1.41) | 0.641 | 0.87 (0.48–1.57) | - | - |
| Among Stented (N=34) | ||||||||
| Alteplase Treatment (27) | 0.103 | 3.96 (0.76–20.67) | 0.507 | 0.52 (0.08–3.56) | 0.764 | 1.32 (0.21–8.24) | 0.653 | 0.56 (0.04–7.21) |
| Any Antiplatelet (23) | 0.260 | 2.29 (0.54–9.63) | 0.380 | 0.45 (0.07–2.68) | 0.204 | 3.12 (0.54–17.97) | 0.999 | # |
| Aspirin (20) | 0.316 | 2.04 (0.51–8.23) | 0.699 | 0.71 (0.12–4.11) | 0.619 | 1.46 (0.33–6.46) | 0.157 | 0.25 (0.04–1.70) |
| DAPT (8) | 0.981 | 0.98 (0.19–5.01) | 0.507 | 1.92 (0.28–13.08) | 0.774 | 1.28 (0.24–6.70) | 0.781 | 1.33 (0.18–10.12) |
| Eptifibatide (8) | 0.396 | 0.50 (0.10–2.48) | 0.507 | 1.92 (0.28–13.08) | 0.568 | 0.59 (0.10–3.57) | 0.463 | 0.47 (0.06–3.57) |